Fig. 3.
Overall survival by TP53 mutation, high complexity, and monosomal karyotype status. a Overall survival of the entire cohort. b Overall survival stratified by TP53 mutation status. c Overall survival stratified by the number of clonal karyotype abnormalities. d Overall survival stratified by monosomal karyotype status. e Stratification of overall survival by TP53 mutation status in patients with a monosomal karyotype. f Stratification of overall survival by TP53 mutation status in patients without a monosomal karyotype